Board weighs written notification, privacy limits in medication‑error policy

Madison Metropolitan School District Operations Work Group · February 10, 2026

Get AI-powered insights, summaries, and transcripts

Subscribe
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

At a second read, the board discussed tightened labeling and notification timeframes for medication incidents, with debate over required written notices and HIPAA/FERPA constraints; staff agreed to refine procedures and consider a parent consent option for written follow‑up.

At their Feb. 9 operations work group, Madison Metropolitan School District staff presented a revised medication administration policy intended to ensure compliance with Wisconsin law and Department of Public Instruction guidance. Key changes included a requirement that self‑carry of nonprescription medications be verified with parent/guardian consent, stronger labeling (manufacturer packaging plus student name), and a clearer time frame for notifying guardians of medication errors or incidents (by 5 p.m. the same day if discovered during school hours, otherwise by noon the next calendar day).

Board members pushed for written notification to families and for clarity on how schools will document incidents. Health services staff said the district already uses internal incident reports that feed into an investigation and that nurses typically make immediate phone contact with guardians. Staff raised HIPAA and FERPA privacy constraints: while the health office conducts internal medical documentation and investigations, distributing detailed written medical records requires proper release or consent, so staff proposed building procedural releases and clear templates rather than embedding overly prescriptive wording in policy.

Several board members requested that the policy explicitly allow families to receive a written summary on request, and staff agreed to explore adding a procedural mechanism — such as a signed release or consent form — to enable written follow‑up without violating medical‑privacy rules. Health staff said medication incidents are relatively rare (they cited district health‑office visit and medication administration volumes) and that reports are used to identify process improvements and root causes when incidents occur.

Next steps: staff will refine the policy procedure language to clarify notification channels and consent/release procedures for written follow‑up and will provide a clean copy for the board’s final vote at an upcoming regular meeting.